After a sleuth reveals a paper with authorships advertised for sale, it’s retracted

Last August 12th, Nick Wise came across a Facebook post advertising the first, third, and fifth author positions for sale on a scientific paper with the same title as a recently published article. Wise, a scientific sleuth whose work has resulted in more than 850 retractions, posted a comment on PubPeer with a screenshot of … Continue reading After a sleuth reveals a paper with authorships advertised for sale, it’s retracted

Paper with authorship posted for sale retracted over a year after Retraction Watch report

More than a year after we reported on two websites advertising authorships of scientific papers for sale, one of the posted articles has been retracted, while publishers say they are still investigating others. The retracted article, “Dynamic simulation of moderately thick annular system coupled with shape memory alloy and multi-phase nanocomposite face sheets,” appeared in … Continue reading Paper with authorship posted for sale retracted over a year after Retraction Watch report

Weekend reads: ‘Against Reviewer 2;’ forced to grant guest authorships; problems in oversight of bat virus research in China

Would you consider a donation to support Weekend Reads, and our daily work? The week at Retraction Watch featured: Our list of retracted or withdrawn COVID-19 papers is up to 289. There are more than 38,000 retractions in our database — which powers retraction alerts in EndNote, LibKey, Papers, and Zotero. And have you seen our leaderboard of authors with the most retractions lately — or … Continue reading Weekend reads: ‘Against Reviewer 2;’ forced to grant guest authorships; problems in oversight of bat virus research in China

Weekend reads: China cracks down; unearned authorship rife; new jargon for a new year

Would you consider a donation to support Weekend Reads, and our daily work? The week at Retraction Watch featured: Our list of retracted or withdrawn COVID-19 papers is up to 283. There are more than 38,000 retractions in our database — which powers retraction alerts in EndNote, LibKey, Papers, and Zotero. And have you seen our leaderboard of authors with the most retractions lately — or … Continue reading Weekend reads: China cracks down; unearned authorship rife; new jargon for a new year

Weekend reads: Russian co-authorship ban; predatory conferences; ‘Does peer review improve the statistical content of manuscripts?’

Would you consider a donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Stanford prof appeals order to pay $428K in legal fees after dropping defamation suit Journal sends cease-and-desist letter to a company marketing a homeopathic alternative to opioids How journal editors kept questionable data about women’s … Continue reading Weekend reads: Russian co-authorship ban; predatory conferences; ‘Does peer review improve the statistical content of manuscripts?’

Journal retracts paper listed on authorship for sale site following Retraction Watch report

An Elsevier journal has retracted a paper that was listed by a firm claiming to sell authorships months after we reported on the site. On Sept. 7, 2021, we published a story about the company, Teziran. On Sept. 14, pseudonymous sleuth Artemisia Stricta wrote to Ioannis Ieropoulos, the editor of Sustainable Energy Technologies and Assessments, … Continue reading Journal retracts paper listed on authorship for sale site following Retraction Watch report

Weekend reads: Should open access advocates vilify publishers?; authorship for sale, $5,000; is economics just ‘bafflegab?’

Would you consider a donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Cancer researcher faked data for 24 images in work funded by nine NIH grants: Federal watchdog The author of a retracted paper learns to be careful what he wishes for Journals acknowledge that a … Continue reading Weekend reads: Should open access advocates vilify publishers?; authorship for sale, $5,000; is economics just ‘bafflegab?’

Weekend reads: A White House official’s retraction; ‘bosom peril;’ nonsense with a forged authorship

Would you consider a donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Exclusive: How a researcher faked data and gaslit a labmate for years COVID-19 spike protein paper earns an expression of concern Frontiers retracts a dozen papers, many more expected Authors to correct PNAS ‘nudge’ … Continue reading Weekend reads: A White House official’s retraction; ‘bosom peril;’ nonsense with a forged authorship

Weekend reads: A museum of scientific misconduct?; authorship misconduct; uproar over renamed phyla

Would you consider a donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: ‘This is really ridiculous’: An author admitted plagiarism. His supervisor asked for a retraction. The publisher said, “nah.” University of Rochester cancer researchers included ‘incorrect images’ in 13 papers, committee finds Cancer journal with … Continue reading Weekend reads: A museum of scientific misconduct?; authorship misconduct; uproar over renamed phyla

Introducing two sites that claim to sell authorships on scientific papers

Two years ago, we reported on a website based in Russia that claimed to have brokered authorships for more than 10,000 researchers. (Apparently, neither our coverage nor a cease-and-desist letter from Clarivate Analytics had any effect on the site’s operations.) And now, we bring you news of what look like two very similar sites — … Continue reading Introducing two sites that claim to sell authorships on scientific papers